Inmune Bio, Inc. — Director's Dealing 2019

Aug 22, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inmune Bio, Inc. (INMB)
CIK: 0001711754
Period of Report: 2019-08-20

Reporting Person: Juda Scott (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-20	Common Stock	P	2500	$6.00	Acquired	25000	Direct
2019-08-21	Common Stock	P	2500	$6.00	Acquired	27500	Direct

Footnotes

F1: The Reporting Person purchased 2,500 shares of the Issuer's common stock in an open market transaction on August 20, 2019 and 2,5000 shares of the Issuer's common stock in an open market transaction on August 21, 2019.

F2: The Reporting Person's shares are held by Fossick Capital LP ("Fossick"), a limited partnership. The Reporting Person holds all voting and dispositive control over the Issuer's shares of common stock held by Fossick.